$百济神州(BGNE_老虎社区_美港股上老虎

2021-04-08

$百济神州(BGNE)$2021年4月8日，百济神州公布BTK抑制剂泽布替尼治疗呼吸窘迫症状新冠住院患者的二期临床试验最新进展。试验未达到无呼吸衰竭生存或吸氧天数减少的并列主要有效性终点。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":348977525,"tweetId":"348977525","gmtCreate":1617885719467,"gmtModify":1617887381427,"author":{"id":3557091364225232,"authorId":3557091364225232,"authorIdStr":"3557091364225232","name":"vuuron","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/BGNE\">$百济神州(BGNE)$</a>2021年4月8日，百济神州公布BTK抑制剂泽布替尼治疗呼吸窘迫症状新冠住院患者的二期临床试验最新进展。试验未达到无呼吸衰竭生存或吸氧天数减少的并列主要有效性终点。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/BGNE\">$百济神州(BGNE)$</a>2021年4月8日，百济神州公布BTK抑制剂泽布替尼治疗呼吸窘迫症状新冠住院患者的二期临床试验最新进展。试验未达到无呼吸衰竭生存或吸氧天数减少的并列主要有效性终点。</p></body></html>","text":"$百济神州(BGNE)$2021年4月8日，百济神州公布BTK抑制剂泽布替尼治疗呼吸窘迫症状新冠住院患者的二期临床试验最新进展。试验未达到无呼吸衰竭生存或吸氧天数减少的并列主要有效性终点。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/348977525","repostId":0,"isVote":1,"tweetType":1,"viewCount":1205,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BGNE"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":168,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/348977525"}